EIK1005
EIK1005 is a small-molecule inhibitor from Eikon Therapeutics, in registered phase 2 trials for colorectal cancer, endometrial cancer.
Overview
EIK1005 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Eikon Therapeutics, in colorectal cancer, endometrial cancer. Described in the registry record as a eik1005 is a selective inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a eik1005 is a selective inhibitor; the trial entries below carry the sponsor's wording.
1.EIK1005 slips into a pocket on its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"EIK1005" OR ABSTRACT:"EIK1005") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about EIK1005, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentIMP1734
Shares Eikon Therapeutics and the tags pipeline, registry-only.
- TreatmentNP137
Shares Endometrial cancer and the tags pipeline, registry-only.
- TreatmentOnvansertib
Shares Colorectal cancer and the tags pipeline, registry-only.
- TreatmentSotevtamab
Shares Colorectal cancer and the tags pipeline, registry-only.
- TreatmentCT3001
Shares Colorectal cancer and the tags pipeline, registry-only.
- TreatmentTST003
Shares Colorectal cancer and the tags pipeline, registry-only.
- TreatmentVudalimab
Shares Endometrial cancer and the tags pipeline, registry-only.
- TreatmentJMT203
Shares Colorectal cancer and the tags pipeline, registry-only.